Interrelation between the parameters of endogenous vascular regulation, oxidative stress and the markers of inflammatory response in COVID-19 patients while on extracorporeal membrane oxygenation

Introduction. Extracorporeal membrane oxygenation has found wide application in clinical practice during the COVID-19 pandemic. Oxidative stress, endothelial dysfunction, and systemic inflammatory response syndrome play an important role in the pathogenesis of COVID-19. Our research was designed to study correlations in-between those factors and the impact of extracorporeal membrane oxygenation on them.
Aim. The study of systemic inflammatory response and endothelial function in patients with COVID-19 during extracorporeal membrane oxygenation.
Material and methods. In the course of a prospective study, we examined 100 COVID-19 patients aged 26 to 75 years, median 55 years [47;60], who were treated at the N.V. Sklifosovsky Research Institute for Emergency Medicine, using extracorporeal membrane oxygenation. As a control group (normal), 25 practically healthy people whose median age was 32 years [25;39] were examined. The function of the vascular endothelium was assessed by the content of nitric oxide stable metabolites in the blood serum and the level of angiotensin-converting enzyme. Next, the ratio of nitric oxide metabolite to angiotensin-converting enzyme level was calculated, reflecting the imbalance between endotheliumdependent vasodilation and vasoconstriction. To assess the severity of oxidative stress in blood serum, malondialdehyde was determined as a marker of lipid peroxidation. The state of the antioxidant system was assessed in terms of total antioxidant status of blood serum. The presence of an imbalance in the system of lipid peroxidation and the antioxidant system total antioxidant status was judged by the oxidative stress coefficient, i.e. the ratio of malondialdehyde to the total antioxidant activity.
Results. The analysis showed the presence and progression of endothelial dysfunction, impaired vascular regulation, activation of free radical processes, the presence of an imbalance in the prooxidant/antioxidant system, as well as the progression of the inflammatory process with a decrease in the level of markers of the COVID-19 severity.
Conclusion. Further studies of the correlation between endothelial damage and the severity of the systemic inflammatory response syndrome may be of fundamental importance for explaining the pathophysiological mechanisms of COVID-19 course and developing new treatments for such patients.

1. Incalza MA, D'Oria R, Natalicchio A, Perrini S, Laviola L, Giorgino F. Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. Vascul Pharmacol. 2018;100:1–19. PMID: 28579545 https://doi.org/10.1016/j.vph.2017.05.005

2. Russ M, Menk M, Graw JA, Skrypnikov V, Hunsicker O, Rudat K, et al. COVID-19 patients require prolonged extracorporeal membrane oxygenation support for survival compared with nonCOVID-19 patients. Crit Care Explor. 2022;4(4):e0671. https://doi.org/10.1097/CCE.0000000000000671

3. World Health Organization: Weekly Epidemiological Update on COVID-19–17 August 2021. Available at: https://www.who.int/publications/m/item/weekly-epidemiological-update-oncovid-19---17-august-2021 [Accessed December 12, 2022].

4. Extracorporeal Life Support Organization (ELSO) Registry. 2021. Available at: https://www.elso.org/ [Accessed December 12, 2022].

5. Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): pooled analysis of early reports. J Crit Care. 2020;58:27–28. PMID: 32279018 https://doi.org/10.1016/j.jcrc.2020.03.011

6. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. China Medical Treatment Expert Group for C. Clinical characteristics of coronavirus disease 2019 in china. N Engl J Med. 2020;382(18):1708–1720. PMID: 32109013 https://doi.org/10.1056/NEJMoa2002032

7. Levy JH, Iba T, Gardiner EE. Endothelial injury in COVID-19 and acute infections: putting the pieces of the puzzle together. Arterioscler Thromb Vasc Biol. 2021;41(5):1774–1776. PMID: 33792345 https://doi.org/10.1161/ATVBAHA.121.316101

8. Kowalewski M, Fina D, Słomka A, Raffa GM, Martucci G, Coco LV, et al. COVID-19 and ECMO: the interplay between coagulation and inflammation–a narrative review. Crit Care. 2020;24(1):205. PMID: 32384917 https://doi.org/10.1186/s13054-020-02925-3

9. Gavrilov VB, Gavrilova AR, Mazhul LM. Analysis of the procedures for estimation of lipid peroxidation products using thiobarbituriс acid test. Voprosy meditsinskoi khimii. 1987;33(1):118–122. (In Russ.).

10. Bell ML, Rabe BA. The mixed model for repeated measures for cluster randomized trials: a simulation study investigating bias and type I error with missing continuous data. Trials. 2020;21(1):148. PMID: 32033617 https://doi.org/10.1186/s13063-020-4114-9

11. Feng C, Wang H, Lu N, Chen T, He H, Lu Y, et al. Log-transformation and its implications for data analysis. Shanghai Arch Psychiatry. 2014;26(2):105-109. PMID: 25092958 https://doi.org/10.3969/j.issn.1002-0829.2014.02.009

12. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res. 2000;87(10):840-844. PMID: 11073878 https://doi.org/10.1161/01.res.87.10.840

13. Yan C, Kim D, Aizawa T, Berk BC. Functional interplay between angiotensin II and nitric oxide: cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol. 2003;23(1):26–36. PMID: 12524221 https://doi.org/10.1161/01.atv.0000046231.17365.9d

14. Pueyo ME, Arnal JF, Rami J, Michel JB. Angiotensin II stimulates the production of NO and peroxynitrite in endothelial cells. Am J Physiol. 1998;274(1):C214–220. PMID: 9458730 https://doi.org/10.1152/ajpcell.1998.274.1.C214

15. Klychnikova EV, Tazina EV, Solodov AA, Petrikov SS, Godkov MA, Krylov VV. The effects of normobaric hyperoxia on oxidative stress and factors of endogenous vascular regulation in patients who suffered from non-traumatic subarachnoid hemorrhages and remained in critical condition. Neurochemical Journal. 2013;30(3):264–270. (In Russ.).

16. Qin C, Zhou L, Hu Z, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients with Coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis. 2020;71(15):762–768. PMID: 32161940 https://doi.org/10.1093/cid/ciaa248

17. Yang AP, Liu JP, Tao WQ, Li HM. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol. 2020;84:106504. PMID: 32304994 https://doi.org/10.1016/j.intimp.2020.106504

18. Chan AS, Rout A. Use of Neutrophilto-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19. J Clin Med Res. 2020;12(7):448–453. PMID: 32655740 https://doi.org/10.14740/jocmr4240

19. Kazancioglu S, Bastug A, Ozbay BO, Kemirtlek N, Bodur H. The role of haematological parameters in patients with COVID-19 and influenza virus infection. Epidemiol Infect. 2020;148:e272. PMID: 33148349 https://doi.org/10.1017/S095026882000271X

20. Rokni, M, Ahmadikia K, Asghari S, Mashaei S, Hassanali F. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness. BMC Infect Dis. 2020;20(1):869. 3 PMID: 33225909 https://doi.org/10.1186/s12879-020-05540-3

21. Colantuoni A, Martini R, Caprari P, Ballestri M, Capecchi PL, Gnasso A, et al. COVID-19 sepsis and microcirculation dysfunction. Front Physiol. 2020;11:747. PMID: 32676039 https://doi.org/10.3389/fphys.2020.00747

22. Yusuff H, Zochios V, Brodie D. Thrombosis and coagulopathy in COVID-19 patients receiving ECMO: a narrative review of current literature. J Cardiothorac Vasc Anesth. 2022;36(8 Pt B):3312-3317. PMID: 35577652 https://doi.org/10.1053/j.jvca.2022.03.032

23. Carpio-Orantes LD, García-Méndez S, Hernández-Hernández SN. Neutrophilto-lymphocyte ratio, platelet-to-lymphocyte ratio and systemic immuneinflammation index in patients with COVID-19-associated pneumonia. Gac Med Mex. 2020;156(6):527–531. PMID: 33877106 https://doi.org/10.24875/GMM.M21000480

24. Hirahara T, Arigami T, Yanagita S, Matsushita D, Uchikado Y, Kita Y, et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer. BMC Cancer. 2019;19(1):672. PMID: 31286873 https://doi.org/10.1186/s12885-019-5903-y

25. Qu R, Ling Y, Zhang YH, Wei L-Y, Chen X, Li X-M, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol. 2020;92(9):1533–1541. PMID: 32181903 https://doi.org/10.1002/jmv.25767